Sale of medicine for respiratory illnesses rose between 2024 and 2025, RS told
Sales of respiratory medicines surged from ₹17,199.40 crore in 2024 to ₹18,912.64 crore in 2025, highlighting increased demand linked to air pollution.
Sales of respiratory medicines surged from ₹17,199.40 crore in 2024 to ₹18,912.64 crore in 2025, highlighting increased demand linked to air pollution.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
